Tonix Pharmaceuticals Holding (TNXP) Finished Goods (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Finished Goods for 3 years, with the latest figure at $2.1 million in Q4 2025.

• On a quarterly basis, Finished Goods fell 58.29% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 58.29% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 58.29% from the prior year.
• Finished Goods was $2.1 million for Q4 2025 at Tonix Pharmaceuticals Holding, up from $1.8 million in the prior quarter.
• The five-year high for Finished Goods was $7.5 million in Q4 2023, with the low at $1.8 million in Q3 2025.
• Average Finished Goods over 3 years is $3.8 million, with a median of $2.6 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Finished Goods tumbled 31.58% in 2024, then sank 58.29% in 2025.
• Over 3 years, Finished Goods stood at $7.5 million in 2023, then plunged by 31.58% to $5.1 million in 2024, then tumbled by 58.29% to $2.1 million in 2025.
• The last three Finished Goods figures came in at $2.1 million (Q4 2025), $1.8 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.